Literature DB >> 9513742

Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia.

M R Johnson1, D Marazziti, O Brawman-Mintzer, N P Emmanuel, M R Ware, W A Morton, A Rossi, G B Cassano, R B Lydiard.   

Abstract

BACKGROUND: Peripheral benzodiazepine receptors (PBRs) are involved in regulating stress responses. Abnormally low numbers of platelet PBRs have been found in patients with panic disorder, posttraumatic stress disorder, and generalized anxiety disorder, but not in patients with obsessive-compulsive disorder (OCD) or major depressive disorder (MDD). The purpose of this study was to evaluate the PBR density on platelets from patients with generalized social phobia (GSP).
METHODS: The density (Bmax) and dissociation constant (Kd) of platelet PBRs was determined for 53 medication-free patients with GSP and an equal number of control subjects (NC).
RESULTS: The GSP group was found to have a significantly lower PBR Bmax than the NC group (GSP = 2764 +/- 1242 vs. NC = 4327 +/- 1850 fmol/mg protein, df = 1,100, F = 22.7, p = .00001).
CONCLUSIONS: GSP shares this PBR abnormality with some other anxiety disorders but not with OCD or MDD. PBRs may play a role in the pathophysiology of some anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513742     DOI: 10.1016/S0006-3223(97)00390-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms.

Authors:  Stefano Pini; Claudia Martini; Marianna Abelli; Matteo Muti; Camilla Gesi; Marina Montali; Beatrice Chelli; Antonio Lucacchini; Giovanni B Cassano
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 3.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.

Authors:  Jonas Hannestad; Nicole DellaGioia; Jean-Dominique Gallezot; Keunpoong Lim; Nabeel Nabulsi; Irina Esterlis; Brian Pittman; Jae-Yun Lee; Kevin C O'Connor; Daniel Pelletier; Richard E Carson
Journal:  Brain Behav Immun       Date:  2013-07-09       Impact factor: 7.217

Review 5.  Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?

Authors:  Rainer Rupprecht; Christian H Wetzel; Mario Dorostkar; Jochen Herms; Nathalie L Albert; Jens Schwarzbach; Michael Schumacher; Inga D Neumann
Journal:  Mol Psychiatry       Date:  2022-04-20       Impact factor: 15.992

6.  Neurosteroids as neuromodulators in the treatment of anxiety disorders.

Authors:  Patrizia Longone; Flavia di Michele; Elisa D'Agati; Elena Romeo; Augusto Pasini; Rainer Rupprecht
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-19       Impact factor: 5.555

7.  Changes in peripheral benzodiazepine receptors in patients with bipolar disorder.

Authors:  Donatella Marazziti; Bernardo Dell'Osso; Stefano Baroni; Irene Masala; Elena Di Nasso; Gino Giannaccini; Liliana Dell'Osso
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

8.  Expression and purification of the mammalian translocator protein for structural studies.

Authors:  Elisabeth Graeber; Volodymyr M Korkhov
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.